All stock lists
Puma Biotechnology, Inc. (NASDAQ:PBYI)
US · Delayed Price · Currency is USD
10.85-0.17 (-1.59%)
Insider Score
––Not scored
PBYI Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
PBYI analyst forecast
PBYI analyst consensus
Hold1 ratings
Buy 0 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
PBYI 12-month price target
No published price targets in the last 12 months.
Best analysts covering PBYI
No firm covering PBYI has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
PBYI analyst ratings
| Analyst | Firm | Rating | Price target | Upside | Action | Date |
|---|---|---|---|---|---|---|
| — | TD Cowen | Hold | — | — | Reiterated | 2026-08-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-02-28 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-12-23 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-20 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-08 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-02 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-07-26 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-06-04 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-06-03 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-20 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-03 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-03-01 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-02-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-09-20 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-08-04 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-06-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-03-06 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-08-31 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-08-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-05-06 |
| — | Citigroup | Buy | — | — | Upgraded | 2021-09-28 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2021-08-06 |
| — | Goldman Sachs | Sell | — | — | Reiterated | 2021-08-06 |
| — | Citigroup | Neutral | — | — | Reiterated | 2020-08-10 |
| — | SVB Leerink | Market Perform | — | — | Reiterated | 2020-08-07 |
| — | B of A Securities | Underperform | — | — | Reiterated | 2020-06-25 |
| — | Cantor Fitzgerald | Neutral | — | — | Reiterated | 2020-05-20 |
| — | H.C. Wainwright | Buy | — | — | Reiterated | 2019-12-06 |
| — | Goldman Sachs | Sell | — | — | Downgraded | 2019-10-08 |
| — | Barclays | Underweight | — | — | Reiterated | 2019-08-09 |
| — | Citi | Neutral | — | — | Downgraded | 2019-05-10 |
| — | Citigroup | Neutral | — | — | Downgraded | 2019-05-10 |
| — | Cantor Fitzgerald | Neutral | — | — | Downgraded | 2019-05-10 |
| — | Citigroup | Buy | — | — | Reiterated | 2019-03-01 |
| — | Leerink Swann | Perform | — | — | Reiterated | 2019-01-17 |
| — | Guggenheim | Neutral | — | — | Downgraded | 2019-01-03 |
| — | Goldman Sachs | Neutral | — | — | Upgraded | 2018-11-19 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2018-11-02 |
| — | Barclays | Underweight | — | — | Downgraded | 2018-11-02 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2018-11-02 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2018-10-01 |
| — | Citigroup | Buy | — | — | Reiterated | 2018-09-18 |
| — | Goldman Sachs | Sell | — | — | Reiterated | 2018-09-17 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2018-08-10 |
| — | Citigroup | Buy | — | — | Reiterated | 2018-06-28 |
| — | Barclays | Equal Weight | — | — | Downgraded | 2018-04-12 |
| — | Stifel | Buy | — | — | Reiterated | 2018-03-09 |
| — | Stifel Nicolaus | Buy | — | — | Reiterated | 2018-03-09 |
| — | Barclays | Overweight | — | — | Reiterated | 2018-03-02 |
| — | Citigroup | Buy | — | — | Reiterated | 2018-01-24 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2018-01-24 |
| — | Cowen & Co. | Market Perform | — | — | Downgraded | 2018-01-24 |
| — | Bank of America | Buy | — | — | Reiterated | 2018-01-24 |
| — | B of A Securities | Buy | — | — | Reiterated | 2018-01-24 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2018-01-24 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2017-11-10 |
| — | Barclays | Overweight | — | — | Reiterated | 2017-11-10 |
| — | Bank of America | Buy | — | — | Reiterated | 2017-10-09 |
| — | B of A Securities | Buy | — | — | Reiterated | 2017-10-09 |
PBYI earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-26 | 0.24 | 0.29 | $68.6M | $59.9M |
| 2026-05-07 | -0.13 | -0.04 | $42.0M | $44.8M |
| 2026-08-06 | 0.04 | 0.19 | $53.0M | $56.5M |
| 2026-11-05 | 0.09 | 0.00 | $57.5M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.